ArticleAmerican journal of nephrology2019

Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus.

T Cooper Woods et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.